Talaat Moustafa Group raked in EGP 470 billion in sales during 2024 – a volume equivalent to the “total sales of the 9 largest real estate companies in the Egyptian market,” the company’s CEO said late last week.
And the country is getting a slice:
Egypt’s revenues from its partnership with the firm on the “Madinaty” project amounted to EGP 100 billion, Hisham Talaat Moustafa noted.
Impact:
Earlier in August, TMG said 2024 sales would drive its pre-tax profits by about EGP 45 billion over the next four to five years. It also added they would add significant foreign currency inflows to its coffers.
Great performance in 1H:
The company more than quadrupled its net profit in the first six months of the year, recording a 310% YoY rise to EGP 6.36 billion. TMG also hiked its revenues during the period 59% YoY to EGP 17.02 billion
What’s next:
The company plans to add 1500 hotel rooms to its hotel business in Egypt, which is expected to drive the total to 5000. Its local hotel operations are expected to generate over USD 300 million in aggregate revenues, it said.
The firm’s CEO also said TMG is also planning to expand its operations in Iraq as part of its target to increase revenues generated overseas.
Local pharmaceutical company Ibnsina Pharma hiked its profits 134.1% YoY during the first nine months of the year to EGP 406.51 million, its latest earnings disclosure showed.
Sales:
The firm’s sales volume also rose 61.3% YoY to EGP 38.4 billion.
Comes after a strong 1H:
Ibnsina Pharma saw its net income grow 68.3% YoY in the first half of the year to EGP 221.59 million. The company’s revenues similarly rose to EGP 22.8 billion during the period, compared to EGP 14.69 billion in the same interval last year.
Remember:
The company was removed in August from the main EGX30 index (which comprises the most highly capitalized and liquid stocks traded on the Egyptian Exchange) after the bourse completed its semi-annual periodic review of market indices.
Subscribe now to keep reading and get access to the full archive.